Europe Canada Oncology Market Access & Pricing Director

Europe Canada Oncology Market Access & Pricing Director      Are you ready to shape regional access and pricing strategies that get transformative cancer medicines to patients faster across Europe and Canada (EUCAN)?     In this role, you will steer regional strategy and execution for priority oncology portfolios, aligning evidence, value, and pricing to deliver impact at launch and throughout the lifecycle.    Based in Baar, Switzerland and reporting to the Head of EUCAN Oncology Market Access & Pricing, you will operate at the intersection of science, policy, and commercial execution. You will partner closely with global, regional, and country teams to navigate EU HTA implementation, evolving evidence requirements, international reference pricing, and shifting oncology funding models, turning complexity into clear, actionable strategies that maximize access and portfolio value.     Can you translate scientific innovation and evolving healthcare trends into regional access strategies that maximize patient impact and portfolio value?    Accountabilities  Regional Strategy & Execution : Translate global oncology market access & pricing strategies into regional implementation plans across assigned franchises, bridging global intent with local market realities to deliver timely access outcomes.    Launch & Pricing Excellence : Lead regional access readiness and pricing excellence, optimising list and net price strategies, access conditions, and value realisation to enable best-in-class oncology launches across EUCAN.    Lifecycle Value & Pricing Innovation: Develop pricing, reimbursement, and value strategies across the product lifecycle, including indication sequencing, combination pricing, and evidence-based differentiation in competitive therapeutic areas.    Cross-Functional Partnership: Collaborate with Global Oncology Market Access Pricing (OMAP), Medical, HEOR, Policy, Government Affairs, and Commercial teams to ensure evidence generation plans and value propositions meet payer and HTA requirements at regional and country level.    External Environment & Policy Shaping: Monitor and assess the implications of EU HTA, international reference pricing dynamics incl. MFN, and evolving oncology funding models; translate insights into pragmatic regional guidance.    Country Enablement: Build strategic partnerships with country market access leaders to drive excellence execution, share best practice, and strengthen local capabilities.    Business Planning Integration: Embed market access and pricing assumptions into business planning and forecasting cycles to inform investment decisions and portfolio prioritization.    Governance & Representation: Represent EUCAN market access perspectives in regional and global governance forums, ensuring priorities, risks, and opportunities are visible and addressed.    Essential Skills & Experience  Qualification: Master’s degree in health economics, Economics, Life Sciences, or a closely related discipline.    Market Access Expertise: 10+ years' experience in Market Access, Pricing, or HEOR within the pharmaceutical industry, with significant oncology experience.  European Payer Knowledge: Demonstrated, hands-on understanding of European HTA and reimbursement systems including familiarity with the EU HTA regulation and its implementation timeline.    Pricing & Reimbursement Strategy: Proven track record of developing and executing successful pricing and access strategies across multiple European markets,   Launch Experience: Direct involvement in at least two major oncology product launches in a regional or multi-country capacity.    Stakeholder Influence: Demonstrated ability to influence senior leaders and drive alignment in highly matrixed, global organisations without direct line authority.    Strategic Acumen: Ability to synthesise complex policy, competitive, and market dynamics into clear, commercially sound recommendations for senior leadership.    Communication: Excellent written and verbal communication skills in English, including executive-level presentation and storytelling capability.      Desirable Skills & Experience    Direct experience negotiating pricing and reimbursement with European payers or HTA bodies, including innovative access agreements, value-based arrangements or managed entry agreements.    Experience influencing evidence generation, value demonstration, or HEOR strategies to support payer and HTA decision-making.     Experience working across Global, Regional, and Affiliate organizations in highly matrixed environments.    Fluency in one or more additional European languages      When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.    I&D  We are proud to have a unique workplace culture that inspires innovation and collaboration! Here, employees are empowered to express diverse perspectives - and are made to feel valued, energized and rewarded for their ideas and creativity.    Why AstraZeneca  Here you will help turn cutting-edge science into real access for patients, working in a fast-moving environment that mixes rigorous evidence with imaginative access solutions. We bring uncommon combinations of experts together to spark bold thinking, co-create value narratives with our medical and HEOR partners, and pioneer innovative value strategies with payers that stand up to the toughest scrutiny. You will find the ambition to set new industry standards balanced with support, trust, and kindness, so you can take smart risks, learn quickly, and see your work translate into faster, broader access to life-changing oncology medicines.    So, what is next:  If you’re ready to lead regional access and pricing strategy that shapes the future of oncology across EUCAN, step forward and help us deliver more medicines to more patients, sooner.  Welcome with your application, in English.      Where can I find out more?  Follow AstraZeneca on LinkedIn: https://www.linkedin.com/company/1603/  Inclusion & Diversity: Inclusion and diversity  Career site: https://careers.astrazeneca.com/  Date Posted 12-juni-2026 Closing Date 26-juni-2026 AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.